Related topics: breast cancer

DNA nanorobots target HER2-positive breast cancer cells

According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal growth factor receptor 2 (HER2). When displayed on the surface of cancer cells, this signaling protein ...

High speed cancer profiling

(Phys.org) —Identify the type of cancer for patients with breast cancer in a few minutes. This is the challenge that EPFL researchers successfully met by presenting their new "microfluidic chip." Their research is written ...

Turning off cancer's growth signals

One hallmark of cancer cells is uncontrollable growth, provoked by inappropriate signals that instruct the cells to keep dividing. Researchers at MIT and Brigham and Women’s Hospital have now identified a new way to ...

Tracking therapeutic nanoparticles that target breast tumors

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumors. ...

HER2/neu

HER2/neu (also known as ErbB-2) stands for "Human Epidermal growth factor Receptor 2" and is a protein giving higher aggressiveness in breast cancers. It is a member of the ErbB protein family, more commonly known as the epidermal growth factor receptor family. HER2/neu has also been designated as CD340 (cluster of differentiation 340) and p185. It is encoded by the ERBB2 gene.

This text uses material from Wikipedia, licensed under CC BY-SA